Palliative care for caregivers should be initiated earlier rather than later
the ONA take:
A team of investigators, affiliated with University of Alabama at Birmingham, School of Nursing/Department of Medicine, examined the impact of early versus delayed intervention with regard to family caregivers for those with cancer.
For a period of slightly over 2 years, the researchers selected caregivers of patients with advanced cancer to receive intervention either soon after enrollment of 3 months afterward. Caregivers were recruited from a National Cancer Institute (NCI) cancer center, a Veterans Administration Medical Center, and two community outreach clinics. Intervention consisted of the following: three telephone coaching sessions per week, a monthly follow-up, and a bereavement call. One hundred twenty two caregivers participated in the study process.
Measured factors for caregivers in the two groups were depression, quality of life, and burden (objective, stress, and demand).
Data showed a lower rate of depression (both at the three-month mark and in terminal decline analysis) for the caregivers in the early group. The early intervention group also demonstrated lower stress burden, though quality of life was rated similar for both groups.
Study results were presented at the 50th Annual Meeting of the American Society of Clinical Oncology, in Chicago, Illinois.
The impact of early versus delayed intervention with regard to family caregivers for those with cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|